Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1996-12-24
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544325, A61K 31405, C07D23948
Patent
active
055873804
ABSTRACT:
A class of substituted phenylpyrimidine compounds are disclosed which are potent inhibitors of the excitatory amino acid, glutamate. Such compounds are useful in the treatment or prevention of a range of CNS disorders including cerebral ischaemic damage and epilepsy.
REFERENCES:
patent: 2624731 (1953-01-01), Hitchings et al.
patent: 4006235 (1977-02-01), Stickney et al.
Russell et. al., J.A.C.S., vol. 73, pp. 3763-3770 (1951).
Falco et. al., British J. of Pharmacology, vol. 6., pp. 185-200 (1951).
Hyde Richard M.
Leach Michael J.
Miller Alistair A.
Nobbs Malcolm S.
Dentz Bernard
Glaxo Wellcome Inc.
LandOfFree
Certain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1178715